middle.news
Boston Scientific sets financing for Penumbra acquisition
8:06am on Saturday 21st of November, 2026 AEDT
•
Healthcare
Read Story
Boston Scientific sets financing for Penumbra acquisition
8:06am on Saturday 21st of November, 2026 AEDT
Key Points
US$3 billion across four senior note tranches
€4.25 billion across six euro-denominated tranches
Proceeds earmarked primarily for the Penumbra acquisition
Euro notes fully and unconditionally guaranteed by Boston Scientific
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Boston Scientific (NYSE:BSX)
OPEN ARTICLE